<DOC>
	<DOCNO>NCT02795260</DOCNO>
	<brief_summary>The investigator recruit 1800 case participant sign ICF , physical examination people , include ecg , X-ray , HIV , blood pressure , specific gamma-interferon detection , collection medical history like .These subject meet standard consider study population I . Population I inject intradermally ESAT6-CFP10 Tuberculin purify protein derivative ( TB-PPD ) different arm subject get least 360 participant whose three kind detection result negative consider study population II.Then , immune Bacillus Calmette -Guerin ( BCG ) vaccine placebo BCG.Do specific gamma-interferon detection skin test , inject intradermally ESAT6-CFP10 TB-PPD different arm subject 12 week immunity .</brief_summary>
	<brief_title>Clinical Study Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 Healthy People Aged 18-65 ( III-healthy )</brief_title>
	<detailed_description>The investigator recruit 1800 case participant sign ICF , physical examination people , include ecg , X-ray , HIV , blood pressure , specific gamma-interferon detection ( γ-IFN ) , collection medical history like .These subject meet standard consider study population I . Population I inject intradermally ESAT6-CFP10 Tuberculin purify protein derivative ( TB-PPD ) different arm subject get least 360 participant whose three kind detection result negative ( specific gamma-interferon detection , TB-PPD ESAT6-CFP10 ) consider study population II.Then , immune Bacillus Calmette -Guerin ( BCG ) vaccine placebo BCG ( BCG palcebo ratio 2:1 ) , incorporate Population III . Do specific gamma-interferon detection skin test , inject intradermally ESAT6-CFP10 TB-PPD different arm subject 12 week immunity . Evaluate specificity ESAT6-CFP10 allergen negative coincidence rate BCG vaccinate crowd , safety ESAT6-CFP10 participant , correlation ESAT6-CFP10 , TB-PPD γ-IFN .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Mycobacterium Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria screen crowd 1 . 1865 year old ; 2. consent sign informed consent form ; 3. comply followup ; 4 . No history tuberculosis ; 5 . Physical condition : obvious heart , liver , kidney , digestive tract , nervous system , mental disorder sign informed consent injection ; 6 . Normal axillary temperature ( quiet condition blow 37.0℃ ) 7 . No abnormal chest Xray check ; Exclusion Criteria screen crowd 1 . Has follow serious disease , advanced cancer , diabetes , chronic obstructive pulmonary disease ( copd ) acute episode , acute/ progressive liver disease kidney disease , congestive heart failure , etc ; 2 . Epilepsy psychiatric patient 3 . Has know suspect ( risk possible ) immune damage abnormal functional , accept glucocorticoid immunosuppressant immunopotentiator treatment , outside gastrointestinal tract protein blood product plasma extraction 3 months； 4 . Has acute febrile diseases infectious disease ; 5. take part new drug clinical trial participate new drug clinical trial within 3 month trial ; 6. clear history drug allergy ； 7 . In pregnancy lactation； 8 . There clear history high blood pressure systolic blood pressure ≥180mmHg , and/or diastolic blood pressure ≥ 100mmHg drug control ； 9 . Researchers consider condition may affect trial evaluation . Inclusion Criteria three negative crowd 1. conform inclusion criterion screen crowd ; 2. result four detection method negative : ESAT6CFP10 、 TB PPD specific gamma IFN HIV ; Exclusion Criteria three negative crowd 1. conform exclusion criterion screen crowd ; 2 . With BCG vaccination taboo .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>ESAT6</keyword>
	<keyword>CFP10</keyword>
	<keyword>skin test</keyword>
	<keyword>diagnostic test</keyword>
</DOC>